Bristol-Myers Squibb Co
1BMY
Company Profile
Business description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Contact
Route 206 and Province Line Road
Princeton
New JerseyNJ08543
USAT: +1 609 252-4621
E: timothy.power@bms.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
34,100
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,913.90 | 66.30 | 0.84% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,593.66 | 1,948.07 | 5.17% |
| FTSE 100 | 7,913.25 | 141.73 | -1.76% |
| HKSE | 20,681.78 | 2,168.03 | -9.49% |
| NASDAQ | 16,387.31 | 1,119.40 | 7.33% |
| Nikkei 225 | 34,609.00 | 828.42 | 2.45% |
| NZX 50 Index | 12,201.43 | 23.85 | -0.20% |
| S&P 500 | 5,268.05 | 188.85 | -3.46% |
| S&P/ASX 200 | 7,709.60 | 41.80 | 0.55% |
| SSE Composite Index | 3,223.64 | 36.83 | 1.16% |